Chronic pulmonary hypertension (CPH) is a devastating disease - its progression is relentless, culminating in right heart failure (RHF) and death in the majority of patients. Unfortunately, our knowledge of the pathophysiologic sequelae that portend cardiac failure with CPH remains grossly inadequate to direct patient care for this increasingly important disease process. Furthermore, the mechanisms of action of common medical and surgical treatment options remain unknown, and the individual patient's response to therapy is unpredictable. Using a standard experimental model of CPH in animals, RHF will be created and studied with two novel techniques: 1.) Right atrial (RA) volume clamping, and 2.) Feedback-loop controlled pulmonary artery (PA) occlusion. The RA volume-clamping technique will permit, for the first time, isolation of the mechanics of RA function, including its contribution to cardiac output and compensatory role in CPH. In addition, feedback-loop controlled PA occlusion will permit differentiation of the indirect vasodilatory effects from the direct myocardial effects of popular therapeutic regimens on right heart mechanics. A series of experiments will assess the impact of common medical therapies and new, as of yet unproven, surgical therapies on right heart function and global cardiac performance. The proposed studies will address the following specific aims: l.) Define the pathophysiologic sequelae of CPH that produce RHF; 2.) Determine the balance between afterload reduction, changes in diastolic relaxation and compliance, and contractile inhibition with common, but poorly understood medical therapeutic agents; and 3.) Determine the physiologic consequences of graded atrial septostomy on right heart function and total cardiac output in subjects with varying degrees of CPH. The long-range goals of this project are to understand the physiologic sequelae of this crippling disease, guide appropriate medical and surgical therapy, and develop, new treatment strategies that will improve outcome for patients with CPH.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069949-02
Application #
6622885
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Gail, Dorothy
Project Start
2002-04-01
Project End
2005-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
2
Fiscal Year
2003
Total Cost
$267,750
Indirect Cost
Name
Washington University
Department
Surgery
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Zierer, Andreas; Voeller, Rochus K; Melby, Spencer J et al. (2009) Impact of calcium-channel blockers on right heart function in a controlled model of chronic pulmonary hypertension. Eur J Anaesthesiol 26:253-9
Moore, Martin L; Newcomb, Dawn C; Parekh, Vrajesh V et al. (2009) STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. J Immunol 183:2016-26
Moore, Martin L; Chi, Michael H; Luongo, Cindy et al. (2009) A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol 83:4185-94
Temino, Viviana M; Peebles Jr, R Stokes (2008) The spectrum and treatment of angioedema. Am J Med 121:282-6
Zhou, Weisong; Newcomb, Dawn C; Moore, Martin L et al. (2008) Cyclooxygenase inhibition during allergic sensitization increases STAT6-independent primary and memory Th2 responses. J Immunol 181:5360-7
Zhou, Weisong; Blackwell, Timothy S; Goleniewska, Kasia et al. (2007) Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells. J Leukoc Biol 81:809-17
Aronoff, David M; Peres, Camila M; Serezani, Carlos H et al. (2007) Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. J Immunol 178:1628-34
Moore, Martin L; Chi, Michael H; Zhou, Weisong et al. (2007) Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity. J Immunol 178:2651-4
Zhou, Weisong; Hashimoto, Koichi; Goleniewska, Kasia et al. (2007) Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol 178:702-10
Talati, Megha; Meyrick, Barbara; Peebles Jr, R Stokes et al. (2006) Oxidant stress modulates murine allergic airway responses. Free Radic Biol Med 40:1210-9

Showing the most recent 10 out of 18 publications